SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today that it will present new data across its pharmaceuticals and diagnostics portfolios at the 19th Clinical Trials on Alzheimer’s Disease (CTAD) Congress, taking place in Boston from November 16-19, 2026. Across 16 accepted abstracts, including two scientific symposia and two oral presentations, Genentech and Roche will highlight its differentiated approach to neurodeg
